Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet

Background and Aims: Precancerous lesions of gastric cancer (PLGC) are the most important pathological phase with increased risk of gastric cancer (GC) and encompass the key stage in which the occurrence of GC can be prevented. In this study, we found that the gut microbiome changed significantly du...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fuhao Chu, Yicong Li, Xiangmei Meng, Yuan Li, Tao Li, Mengyin Zhai, Haocheng Zheng, Tianxi Xin, Zeqi Su, Jie Lin, Ping Zhang, Xia Ding
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/7a7489d82fd14a0e8d3290a029ea4a00
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a7489d82fd14a0e8d3290a029ea4a00
record_format dspace
institution DOAJ
collection DOAJ
language EN
topic precancerous lesions of gastric cancer (PLGC)
gut microbial and metabolic dysbiosis
MNNG
16S rRNA genes sequencing
untargeted metabolomics analysis
Physiology
QP1-981
spellingShingle precancerous lesions of gastric cancer (PLGC)
gut microbial and metabolic dysbiosis
MNNG
16S rRNA genes sequencing
untargeted metabolomics analysis
Physiology
QP1-981
Fuhao Chu
Fuhao Chu
Fuhao Chu
Yicong Li
Xiangmei Meng
Xiangmei Meng
Yuan Li
Yuan Li
Tao Li
Tao Li
Mengyin Zhai
Mengyin Zhai
Haocheng Zheng
Haocheng Zheng
Tianxi Xin
Tianxi Xin
Zeqi Su
Zeqi Su
Jie Lin
Jie Lin
Ping Zhang
Xia Ding
Xia Ding
Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
description Background and Aims: Precancerous lesions of gastric cancer (PLGC) are the most important pathological phase with increased risk of gastric cancer (GC) and encompass the key stage in which the occurrence of GC can be prevented. In this study, we found that the gut microbiome changed significantly during the process of malignant transformation from chronic gastritis to GC in N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) multiple factors-induced rat model. Accumulating evidence has shown that alterations in gut microbiota and metabolism are potentially linked to chronic inflammation and cancer of the gastrointestinal tract. However, the correlation of gut microbiota and metabolites, inflammatory factors, and the potential mechanism in the formation of PLGC have not yet been revealed.Methods: In this study, multiple factors including MNNG, sodium salicylate drinking, ranitidine feed, and irregular diet were used to establish a PLGC rat model. The pathological state of the gastric mucosa of rats was identified through HE staining and the main inflammatory cytokine levels in the serum were detected by the Luminex liquid suspension chip (Wayen Biotechnologies, Shanghai, China). The microbial composition and metabolites in the stool samples were tested by using 16S ribosomal RNA (rRNA) gene sequencing and non-targeted metabolomics. The correlation analysis of gut microbiota and inflammatory cytokines in the serum and gut microbiota and differential metabolites in feces was performed to clarify their biological function.Results: The results showed that compared to the control group, the gastric mucosa of the model rats had obvious morphological and pathological malignant changes and the serum levels of inflammatory cytokines including interleukin-1β (IL-1β), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-10 (IL-10), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and macrophage colony-stimulating factor (M-CSF) increased significantly, while the level of chemokine (C-X-C motif) ligand 1 (CXCL1) in serum reduced significantly. There were significant differences in the composition of the gut microbiota and fecal metabolic profiles between the model and control rats. Among them, Lactobacillus and Bifidobacterium increased significantly, while Turicibacter, Romboutsia, Ruminococcaceae_UCG-014, Ruminococcaceae_UCG-005, and Ruminococcus_1 reduced significantly in the model rats compared to the control rats. The metabolites related to the lipid metabolism and peroxisome proliferator-activated receptor (PPAR) signaling pathway have also undergone significant changes. In addition, there was a significant correlation between the changes of the differential inflammatory cytokines in the serum, fecal metabolic phenotypes, and gut microbial dysbiosis in model rats.Conclusion: The activation of the inflammatory response, disturbance of the gut microbiota, and changes in the fecal metabolic phenotype could be closely related to the occurrence of PLGC. This study provides a new idea to reveal the mechanism of risk factors of chronic gastritis and GC from the perspective of inflammation-immune homeostasis, gut microbiota, and metabolic function balance.
format article
author Fuhao Chu
Fuhao Chu
Fuhao Chu
Yicong Li
Xiangmei Meng
Xiangmei Meng
Yuan Li
Yuan Li
Tao Li
Tao Li
Mengyin Zhai
Mengyin Zhai
Haocheng Zheng
Haocheng Zheng
Tianxi Xin
Tianxi Xin
Zeqi Su
Zeqi Su
Jie Lin
Jie Lin
Ping Zhang
Xia Ding
Xia Ding
author_facet Fuhao Chu
Fuhao Chu
Fuhao Chu
Yicong Li
Xiangmei Meng
Xiangmei Meng
Yuan Li
Yuan Li
Tao Li
Tao Li
Mengyin Zhai
Mengyin Zhai
Haocheng Zheng
Haocheng Zheng
Tianxi Xin
Tianxi Xin
Zeqi Su
Zeqi Su
Jie Lin
Jie Lin
Ping Zhang
Xia Ding
Xia Ding
author_sort Fuhao Chu
title Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
title_short Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
title_full Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
title_fullStr Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
title_full_unstemmed Gut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet
title_sort gut microbial dysbiosis and changes in fecal metabolic phenotype in precancerous lesions of gastric cancer induced with n-methyl-n′-nitro-n-nitrosoguanidine, sodium salicylate, ranitidine, and irregular diet
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/7a7489d82fd14a0e8d3290a029ea4a00
work_keys_str_mv AT fuhaochu gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT fuhaochu gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT fuhaochu gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT yicongli gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT xiangmeimeng gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT xiangmeimeng gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT yuanli gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT yuanli gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT taoli gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT taoli gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT mengyinzhai gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT mengyinzhai gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT haochengzheng gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT haochengzheng gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT tianxixin gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT tianxixin gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT zeqisu gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT zeqisu gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT jielin gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT jielin gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT pingzhang gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT xiading gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
AT xiading gutmicrobialdysbiosisandchangesinfecalmetabolicphenotypeinprecancerouslesionsofgastriccancerinducedwithnmethylnnitronnitrosoguanidinesodiumsalicylateranitidineandirregulardiet
_version_ 1718445220902731776
spelling oai:doaj.org-article:7a7489d82fd14a0e8d3290a029ea4a002021-11-04T05:28:01ZGut Microbial Dysbiosis and Changes in Fecal Metabolic Phenotype in Precancerous Lesions of Gastric Cancer Induced With N-Methyl-N′-Nitro-N-Nitrosoguanidine, Sodium Salicylate, Ranitidine, and Irregular Diet1664-042X10.3389/fphys.2021.733979https://doaj.org/article/7a7489d82fd14a0e8d3290a029ea4a002021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.733979/fullhttps://doaj.org/toc/1664-042XBackground and Aims: Precancerous lesions of gastric cancer (PLGC) are the most important pathological phase with increased risk of gastric cancer (GC) and encompass the key stage in which the occurrence of GC can be prevented. In this study, we found that the gut microbiome changed significantly during the process of malignant transformation from chronic gastritis to GC in N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) multiple factors-induced rat model. Accumulating evidence has shown that alterations in gut microbiota and metabolism are potentially linked to chronic inflammation and cancer of the gastrointestinal tract. However, the correlation of gut microbiota and metabolites, inflammatory factors, and the potential mechanism in the formation of PLGC have not yet been revealed.Methods: In this study, multiple factors including MNNG, sodium salicylate drinking, ranitidine feed, and irregular diet were used to establish a PLGC rat model. The pathological state of the gastric mucosa of rats was identified through HE staining and the main inflammatory cytokine levels in the serum were detected by the Luminex liquid suspension chip (Wayen Biotechnologies, Shanghai, China). The microbial composition and metabolites in the stool samples were tested by using 16S ribosomal RNA (rRNA) gene sequencing and non-targeted metabolomics. The correlation analysis of gut microbiota and inflammatory cytokines in the serum and gut microbiota and differential metabolites in feces was performed to clarify their biological function.Results: The results showed that compared to the control group, the gastric mucosa of the model rats had obvious morphological and pathological malignant changes and the serum levels of inflammatory cytokines including interleukin-1β (IL-1β), interleukin-4 (IL-4), interleukin-6 (IL-6), interleukin-10 (IL-10), interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), and macrophage colony-stimulating factor (M-CSF) increased significantly, while the level of chemokine (C-X-C motif) ligand 1 (CXCL1) in serum reduced significantly. There were significant differences in the composition of the gut microbiota and fecal metabolic profiles between the model and control rats. Among them, Lactobacillus and Bifidobacterium increased significantly, while Turicibacter, Romboutsia, Ruminococcaceae_UCG-014, Ruminococcaceae_UCG-005, and Ruminococcus_1 reduced significantly in the model rats compared to the control rats. The metabolites related to the lipid metabolism and peroxisome proliferator-activated receptor (PPAR) signaling pathway have also undergone significant changes. In addition, there was a significant correlation between the changes of the differential inflammatory cytokines in the serum, fecal metabolic phenotypes, and gut microbial dysbiosis in model rats.Conclusion: The activation of the inflammatory response, disturbance of the gut microbiota, and changes in the fecal metabolic phenotype could be closely related to the occurrence of PLGC. This study provides a new idea to reveal the mechanism of risk factors of chronic gastritis and GC from the perspective of inflammation-immune homeostasis, gut microbiota, and metabolic function balance.Fuhao ChuFuhao ChuFuhao ChuYicong LiXiangmei MengXiangmei MengYuan LiYuan LiTao LiTao LiMengyin ZhaiMengyin ZhaiHaocheng ZhengHaocheng ZhengTianxi XinTianxi XinZeqi SuZeqi SuJie LinJie LinPing ZhangXia DingXia DingFrontiers Media S.A.articleprecancerous lesions of gastric cancer (PLGC)gut microbial and metabolic dysbiosisMNNG16S rRNA genes sequencinguntargeted metabolomics analysisPhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021)